Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Operating Margin: 2019-2024

Historic Operating Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to -6.66%.

  • Eton Pharmaceuticals' Operating Margin fell 1100.00% to -6.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -4.89%, marking a year-over-year increase of 424.00%. This contributed to the annual value of -6.66% for FY2024, which is 289.00% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Operating Margin of -6.66% as of FY2024, which was down 76.71% from -3.77% recorded in FY2023.
  • Eton Pharmaceuticals' Operating Margin's 5-year high stood at -3.77% during FY2023, with a 5-year trough of -69,515.38% in FY2020.
  • For the 3-year period, Eton Pharmaceuticals' Operating Margin averaged around -16.43%, with its median value being -6.66% (2024).
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 6,757,576bps in 2020, then soared by 6,950,854bps in 2021.
  • Eton Pharmaceuticals' Operating Margin (Yearly) stood at -69,515.38% in 2020, then skyrocketed by 6,950,854bps to -6.85% in 2021, then tumbled by 3,202bps to -38.87% in 2022, then soared by 3,510bps to -3.77% in 2023, then plummeted by 289bps to -6.66% in 2024.